CN109105861A - 一种防治四高的海参肽盐及其制备方法 - Google Patents
一种防治四高的海参肽盐及其制备方法 Download PDFInfo
- Publication number
- CN109105861A CN109105861A CN201810943694.0A CN201810943694A CN109105861A CN 109105861 A CN109105861 A CN 109105861A CN 201810943694 A CN201810943694 A CN 201810943694A CN 109105861 A CN109105861 A CN 109105861A
- Authority
- CN
- China
- Prior art keywords
- preparation
- sea cucumber
- salt
- cucumber peptide
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 51
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 150000003839 salts Chemical class 0.000 title claims abstract description 41
- 230000002265 prevention Effects 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 21
- 235000013616 tea Nutrition 0.000 claims abstract description 17
- 240000002234 Allium sativum Species 0.000 claims abstract description 16
- 235000004611 garlic Nutrition 0.000 claims abstract description 16
- 241000241413 Propolis Species 0.000 claims abstract description 15
- 229940069949 propolis Drugs 0.000 claims abstract description 15
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 13
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 13
- 244000000626 Daucus carota Species 0.000 claims abstract description 13
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 13
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 13
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 13
- 241001499733 Plantago asiatica Species 0.000 claims abstract description 13
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims abstract description 11
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 11
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 11
- 235000020339 pu-erh tea Nutrition 0.000 claims abstract description 11
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 10
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 10
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 239000012153 distilled water Substances 0.000 claims description 17
- 241000234282 Allium Species 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 9
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 8
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 229910052708 sodium Inorganic materials 0.000 abstract description 4
- 239000011734 sodium Substances 0.000 abstract description 4
- 238000001694 spray drying Methods 0.000 abstract description 4
- 238000010411 cooking Methods 0.000 abstract description 3
- 230000010354 integration Effects 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 239000002304 perfume Substances 0.000 abstract description 2
- 230000008719 thickening Effects 0.000 abstract description 2
- 244000291564 Allium cepa Species 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 34
- 241001122767 Theaceae Species 0.000 description 11
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 10
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 10
- 229940116269 uric acid Drugs 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 7
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
- 241000207925 Leonurus Species 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000005360 mashing Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 240000007890 Leonurus cardiaca Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- -1 Compound salt Chemical class 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000001627 cerebral artery Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明提供了一种防治四高的海参肽盐及其制备方法,包括以下步骤:将食盐溶解在茶水提取液中,加入海参肽、调味粉末、中药提取物、蜂胶和麦芽糊精,搅拌混合后均匀,经喷雾干燥,即可得到所述防治四高的海参肽盐。茶水提取液的原料为普洱茶;调味粉末的原料为大蒜、洋葱、胡萝卜、西红柿;中药提取液的原料为三七、川芎、益母草、葛根、车前草。以上这些原料按照本发明提供的方法添加麦芽糊精和蜂胶增粘后经喷雾干燥制备得到的食用盐,所得食用盐的颗粒均匀,各成分经过喷雾干燥后能有效融合,且钠含量较低,鲜香十足,作为食物烹饪时的溶解性较好,尤其适用于四高患者食用。
Description
技术领域
本发明涉及食用盐制备技术领域,具体涉及一种防治四高的海参肽盐及其制备方法。
背景技术
随着人们生活水平的提高和生活节奏的加快而导致的体育活动的减少,越来越多的疾病不断跻身于影响人们的健康、生活质量甚至生命的因素行列,“三高”是人们在生活中经常听到的一个词语,所谓“三高”即高血压、高血脂和高血糖,高尿酸症是与高血压、高血脂、高血糖等密切相关的代谢综合征,被称为“第四高”。近年来,此病的发病率呈上升趋势,而且,高尿酸症患者往往也合并有其他“三高”。尿酸是嘌呤代谢的终末产物,体内嘌呤代谢紊乱,使血尿酸生成过多,或肾脏排泄尿酸减少,使体内血尿酸升高,在长期高尿酸症的情况下,就会导致通风的发生。
人们在日常的食品烹饪中,食盐多是作为提咸、增味的功能,对于大部分家庭厨房所使用的食盐多是常规的碘盐或者钾盐,功能性较为单一,而市场上具有特定功能的低钠复合食盐的品种较少,而具有四高防治功能的复合食盐更少。
发明内容
本发明的目的在于提供一种防治四高的海参肽盐及其制备方法,其具有增咸、提鲜、低钠的特点,特别添加了菌菇小肽、茶水提取物和中药提取物,具有治疗和预防三高病症的作用,尤其适用于三高人群食用。
本发明采取的技术方案为:
一种防治四高的海参肽盐的制备方法,包括以下步骤:
S1、制备海参肽;
S2、制备以普洱茶为原料的茶水提取液;
S3、制备以大蒜、洋葱、胡萝卜、西红柿为原料的调味粉末;
S4、制备以三七、川芎、益母草、葛根、车前草为原料的中药提取物;
S5、将食盐溶解在茶水提取液中,加入海参肽、调味粉末、中药提取物、蜂胶和麦芽糊精,搅拌混合后均匀,经喷雾干燥,即可得到所述防治四高的海参肽盐。
进一步地,上述各原料的重量比如下:食盐:海参肽:茶水提取液:调味粉末:中药提取物:麦芽糊精:蜂胶=1:0.07~0.18:10~20:0.05~0.15:2.0~5.0:0.01~0.05:0.01~0.05。
步骤S1中,所述海参肽的制备方法为:将海参粉碎后与蒸馏水混合,调节体系pH为7.8~8.2,接入胰蛋白酶进行酶解,酶解结束后,经微波灭酶、过滤,滤液经浓缩干燥即可得到所述海参肽。
步骤S1中,所述海参与蒸馏水的质量之比为1:6~10;所述胰蛋白酶的添加量为6000~10000U/g;所述酶解的温度为55~65℃,酶解时间为4~6h;所述所述微波灭酶的条件为400~450W、3~5min。
步骤S2中,所述茶水提取液的制备方法为:将普洱茶与蒸馏水混合,反复煎煮三次,合并煎煮液,并将煎煮液浓缩至原有体积的50%。
步骤S2中,所述普洱茶与蒸馏水的质量之比为1:10~15。
步骤S3中,所述调味粉末的制备方法为:将大蒜、洋葱、胡萝卜、西红柿切块后混合,再加入蒸馏水和柠檬酸,在破壁机中进行打浆处理,浆液过滤后,滤液经减压、浓缩、干燥,即可得到所述调味粉末。破壁机进行打浆处理,可深入破坏以上原料的细胞壁,使其内容的营养物质溶出到浆液中,柠檬酸的加入,可对浆液进行护色处理,以防止发生褐变。
步骤S3中,所述大蒜、洋葱、胡萝卜、西红柿质量之比为1:1.5~3:1.5~3:1.5~3。
步骤S3中,所述大蒜与蒸馏水、柠檬酸的质量之比为1:8~12:0.005~0.10。
步骤S4中,所述中药提取液的制备方法为:将三七、川芎、益母草、葛根、车前草混合,并粉碎至粒径在100目以下,按照料液比1g:5~10mL放入50~75%的乙醇水溶液中浸泡2~4h;然后升温至50~60℃,采用微波辅助提取法进行提取,结束后,过滤,滤液经浓缩、干燥,即可得到所述中药提取物。
步骤S4中,三七、川芎、益母草、葛根、车前草的质量比为1:0.8~1.2:1.5~3.0:1.0~2.0:1.0~2.5。
步骤S4中,所述微波辅助提取法的条件为微波功率320~540W,提取时间1.5~3.0h。微波辅助提取法的提取条件温和,相对于煎煮法而言,可最大程度地保护中药的有效成分,并且提取效率较高。
本发明还提供了根据所述的制备方法制备得到的防治四高的海参肽盐。
本发明提供的防治四高的海参肽盐的配方中,海参味甘性温,有补肾益精、养血润澡、延年益寿之功效。但是海参作为高营养的海产品,其嘌呤含量较高,不利于高尿酸人群食用。而海参经胰蛋白酶处理后得到的海参肽,其分子量较低,海参肽能抑制ACE活性,因而能防止血管末稍收缩起到降血压作用,能迅速消除疲劳症状,恢复体力,能增强人体免疫功能,抵御病毒侵袭,而且还能抑制肿瘤细胞的生长和转移。
普洱茶中的茶氨酸能起到抑制血压升高的作用,而生物碱和类黄酮物质有使血管壁松驰,增加血管的有效直径,通过使血管舒张而使血压下降;同时,它们又因能兴奋血管运动中枢,直接舒张肾血管,增加肾血流量,从而增加了肾小球的滤过率,具有利尿作用,可有效促使尿酸的排出。
大蒜、洋葱、胡萝卜、西红柿均是低嘌呤食物,大蒜和洋葱具有辛辣味、胡萝卜具有微甜味,西红柿具有酸味,以他们组合进行提取之后得到的粉末,具有调味、增香、提鲜的功能,而且还具有降压、软化血管的作用。
中药提取物是以三七、川芎、益母草、葛根、车前草经微波辅助提取法提取得到的物质。三七具有散瘀止血,消肿定痛之功效,其有效成分中的三七皂苷能够降低血液中的血脂、血糖和胆固醇的含量,它可以软化血管,疏通和扩张血管,有效的分解和抑制血管中的细小血栓,对高血脂,脑梗塞等心脑血管疾病有显著疗效;川芎活血行气,祛风止痛,其有扩张冠状动脉、脑动脉的功效,改善微循环的作用,并有明显而持久的降压作用。益母草具有利尿通淋的作用,促进肾脏尿酸排泄;葛根中含有人体所需的多种氨基酸和微量元素,具有扩张冠状动脉和脑动脉的作用,能够有效降低血压,增加缺血组织的血液供应量,能明显降低心肌耗氧量,降低胆固醇和血粘度,改善血液循环;车前草具有利尿作用,可促进体内的尿素、尿酸及氯化钠的排出,以上这些中药作为原料经有效成分提取后,协同作用,具有软化尿酸沉积结石、祛湿解毒、通络止痛、降压降脂、利尿利水的功效。
蜂胶是蜜蜂采集树脂并混入其上颚腺分泌物形成的一种固体胶状物,蜂胶中有近70余种类黄酮物质,其中的黄芪素、梓醇等活性成分可以中和体内的尿酸,促进体内的血糖合成肝糖原,通过尿液将血糖、脂肪酸排出,可以让身体起到偏碱性的作用,此外蜂胶作为海参肽盐的原料,还可提高盐水的粘度,与麦芽糊精配合作用,可增加其他原料与食盐的粘结力。
以上这些原料按照本发明提供的方法添加麦芽糊精和蜂胶增粘后经喷雾干燥制备得到的食用盐,所得食用盐的颗粒均匀,各成分经过喷雾干燥后能有效融合,且钠含量较低,鲜香十足,作为食物烹饪时的溶解性较好,尤其适用于四高患者食用。
虽然食盐在人们的饮食中所占的比例较小,但是也是三餐不可缺少的佐料之一,本发明公开的海参肽盐,长期使用后,可减少人们对于高钠食盐和其他鸡精等调味品的摄入,用于预防四高病症的发生,且其经科学配比后,具有增咸、提香的功能。
具体实施方式
下面结合实施例对本发明进行详细说明。
实施例1
一种防治四高的海参肽盐的制备方法,包括以下步骤:
S1、制备海参肽:将海参粉碎后,按照质量比1:6与蒸馏水混合,调节体系pH为8.2,按照7500U/g的接入量接入胰蛋白酶55℃酶解6h,酶解结束后,经450W微波灭酶3min、过滤,滤液经浓缩干燥即可得到所述海参肽;
S2、制备以普洱茶为原料的茶水提取液:将普洱茶与蒸馏水按照质量比1:10混合,反复煎煮三次,合并煎煮液,并将煎煮液浓缩至原有体积的50%;
S3、制备以大蒜、洋葱、胡萝卜、西红柿为原料的调味粉末:将大蒜、洋葱、胡萝卜、西红柿切块后按照质量比1:3:1.5:3混合,再加入蒸馏水和柠檬酸,所述大蒜与蒸馏水、柠檬酸的质量之比为1:12:0.10,在破壁机中进行打浆处理,浆液过滤后,滤液经减压、浓缩、干燥,即可得到所述调味粉末;
S4、制备以三七、川芎、益母草、葛根、车前草为原料的中药提取物:将三七、川芎、益母草、葛根、车前草按照重量比1:1.2:3.0:1.0:1.0混合,并粉碎至粒径在100目以下,按照料液比1g:10mL放入50%的乙醇水溶液中浸泡4h;然后升温至60℃,采用微波辅助提取法于320W提取3.0h,结束后,过滤,滤液经浓缩、干燥,即可得到所述中药提取物;
S5、按照食盐:海参肽:茶水提取液:调味粉末:中药提取物:麦芽糊精:蜂胶=1:0.18:20:0.10:3.2:0.04:0.05的重量比准备原料,将食盐溶解在茶水提取液中,升温至35℃,加入海参肽、调味粉末、中药提取物、蜂胶和麦芽糊精,以800r/min的转速搅拌20min,搅拌混合后均匀,经喷雾干燥,即可得到所述防治四高的海参肽盐。
实施例2
一种防治四高的海参肽盐的制备方法,包括以下步骤:
S1、制备海参肽:将海参粉碎后,按照质量比1:10与蒸馏水混合,调节体系pH为7.8,按照10000U/g的接入量接入胰蛋白酶65℃酶解4h,酶解结束后,经400W微波灭酶5min、过滤,滤液经浓缩干燥即可得到所述海参肽;
S2、制备以普洱茶为原料的茶水提取液:将普洱茶与蒸馏水按照质量比1:15混合,反复煎煮三次,合并煎煮液,并将煎煮液浓缩至原有体积的50%;
S3、制备以大蒜、洋葱、胡萝卜、西红柿为原料的调味粉末:将大蒜、洋葱、胡萝卜、西红柿切块后按照质量比1:1.5:3:3混合,再加入蒸馏水和柠檬酸,所述大蒜与蒸馏水、柠檬酸的质量之比为1:8:0.005,在破壁机中进行打浆处理,浆液过滤后,滤液经减压、浓缩、干燥,即可得到所述调味粉末;
S4、制备以三七、川芎、益母草、葛根、车前草为原料的中药提取物:将三七、川芎、益母草、葛根、车前草按照重量比1:1.0:2.6:1.4:1.7混合,并粉碎至粒径在100目以下,按照料液比1g:7mL放入75%的乙醇水溶液中浸泡2h;然后升温至50℃,采用微波辅助提取法于540W提取1.5h,结束后,过滤,滤液经浓缩、干燥,即可得到所述中药提取物;
S5、按照食盐:海参肽:茶水提取液:调味粉末:中药提取物:麦芽糊精:蜂胶=1:0.07:14:0.08:4.4:0.03:0.05的重量比准备原料,将食盐溶解在茶水提取液中,升温至35℃,加入海参肽、调味粉末、中药提取物、蜂胶和麦芽糊精,以1000r/min的转速搅拌15min,搅拌混合后均匀,经喷雾干燥,即可得到所述防治四高的海参肽盐。
根据本发明的制备方法得到的海参肽盐添加到食物中之后,可同时具有增香、提鲜、增咸的功能,可省去添加其他调味品,降低普通食盐的摄入量。特别添加的海参肽、中药提取物及蜂胶,长期使用可防治四高病症。
上述参照实施例对一种防治四高的海参肽盐及其制备方法进行的详细描述,是说明性的而不是限定性的,可按照所限定范围列举出若干个实施例,因此在不脱离本发明总体构思下的变化和修改,应属本发明的保护范围之内。
Claims (10)
1.一种防治四高的海参肽盐的制备方法,其特征在于,包括以下步骤:
S1、制备海参肽;
S2、制备以普洱茶为原料的茶水提取液;
S3、制备以大蒜、洋葱、胡萝卜、西红柿为原料的调味粉末;
S4、制备以三七、川芎、益母草、葛根、车前草为原料的中药提取物;
S5、将食盐溶解在茶水提取液中,加入海参肽、调味粉末、中药提取物、蜂胶和麦芽糊精,搅拌混合后均匀,经喷雾干燥,即可得到所述防治四高的海参肽盐。
2.根据权利要求1所述的制备方法,其特征在于,各原料的重量比如下:食盐:海参肽:茶水提取液:调味粉末:中药提取物:麦芽糊精:蜂胶=1:0.07~0.18:10~20:0.05~0.15:2.0~5.0:0.01~0.05:0.01~0.05。
3.根据权利要求1或2所述的制备方法,其特征在于,步骤S1中,所述海参肽的制备方法为:将海参粉碎后与蒸馏水混合,调节体系pH为7.8~8.2,接入胰蛋白酶进行酶解,酶解结束后,经微波灭酶、过滤,滤液经浓缩干燥即可得到所述海参肽。
4.根据权利要求1所述的制备方法,其特征在于,步骤S2中,所述茶水提取液的制备方法为:将普洱茶与蒸馏水混合,反复煎煮三次,合并煎煮液,并将煎煮液浓缩至原有体积的50%。
5.根据权利要求1所述的制备方法,其特征在于,步骤S3中,所述调味粉末的制备方法为:将大蒜、洋葱、胡萝卜、西红柿切块后混合,再加入蒸馏水和柠檬酸,在破壁机中进行打浆处理,浆液过滤后,滤液经减压、浓缩、干燥,即可得到所述调味粉末。
6.根据权利要求1或5所述的制备方法,其特征在于,步骤S3中,所述大蒜、洋葱、胡萝卜、西红柿质量之比为1:1.5~3:1.5~3:1.5~3。
7.根据权利要求1所述的制备方法,其特征在于,步骤S4中,所述中药提取液的制备方法为:将三七、川芎、益母草、葛根、车前草混合,并粉碎至粒径在100目以下,按照料液比1g:5~10mL放入50~75%的乙醇水溶液中浸泡2~4h;然后升温至50~60℃,采用微波辅助提取法进行提取,结束后,过滤,滤液经浓缩、干燥,即可得到所述中药提取物。
8.根据权利要求1或7所述的制备方法,其特征在于,步骤S4中,三七、川芎、益母草、葛根、车前草的质量比为1:0.8~1.2:1.5~3.0:1.0~2.0:1.0~2.5。
9.根据权利要求1或7所述的制备方法,其特征在于,步骤S4中,所述微波辅助提取法的条件为微波功率320~540W,提取时间1.5~3.0h。
10.根据权利要求1-9任意一项所述的制备方法制备得到的防治四高的海参肽盐。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810943694.0A CN109105861A (zh) | 2018-08-18 | 2018-08-18 | 一种防治四高的海参肽盐及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810943694.0A CN109105861A (zh) | 2018-08-18 | 2018-08-18 | 一种防治四高的海参肽盐及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109105861A true CN109105861A (zh) | 2019-01-01 |
Family
ID=64852397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810943694.0A Withdrawn CN109105861A (zh) | 2018-08-18 | 2018-08-18 | 一种防治四高的海参肽盐及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109105861A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208091A (zh) * | 2021-03-29 | 2021-08-06 | 江苏省盐业集团有限责任公司 | 添加肽的调味盐及其制备方法和用途 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103549366A (zh) * | 2013-10-23 | 2014-02-05 | 中盐安徽盐化集团股份有限公司 | 一种绿茶食用盐的制备方法 |
CN105249411A (zh) * | 2015-11-20 | 2016-01-20 | 大连雅特盐业有限公司 | 一种水果、蔬菜调味盐及其制备方法 |
CN105410853A (zh) * | 2015-10-29 | 2016-03-23 | 中盐榆林盐化有限公司 | 一种蒜香盐及其制备方法 |
CN105876390A (zh) * | 2014-09-12 | 2016-08-24 | 天津科技大学 | 一种具有抗氧化性的陈皮功能盐 |
CN105919021A (zh) * | 2016-05-03 | 2016-09-07 | 王胜 | 一种含海盐和紫菜提取物的植物盐及其制备方法 |
CN106666638A (zh) * | 2016-12-29 | 2017-05-17 | 天津保元堂生物科技有限公司 | 一种苦荞药膳盐及其制备方法 |
CN107801974A (zh) * | 2017-12-21 | 2018-03-16 | 大连深蓝肽科技研发有限公司 | 一种海参肽盐的制备方法 |
-
2018
- 2018-08-18 CN CN201810943694.0A patent/CN109105861A/zh not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103549366A (zh) * | 2013-10-23 | 2014-02-05 | 中盐安徽盐化集团股份有限公司 | 一种绿茶食用盐的制备方法 |
CN105876390A (zh) * | 2014-09-12 | 2016-08-24 | 天津科技大学 | 一种具有抗氧化性的陈皮功能盐 |
CN105410853A (zh) * | 2015-10-29 | 2016-03-23 | 中盐榆林盐化有限公司 | 一种蒜香盐及其制备方法 |
CN105249411A (zh) * | 2015-11-20 | 2016-01-20 | 大连雅特盐业有限公司 | 一种水果、蔬菜调味盐及其制备方法 |
CN105919021A (zh) * | 2016-05-03 | 2016-09-07 | 王胜 | 一种含海盐和紫菜提取物的植物盐及其制备方法 |
CN106666638A (zh) * | 2016-12-29 | 2017-05-17 | 天津保元堂生物科技有限公司 | 一种苦荞药膳盐及其制备方法 |
CN107801974A (zh) * | 2017-12-21 | 2018-03-16 | 大连深蓝肽科技研发有限公司 | 一种海参肽盐的制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208091A (zh) * | 2021-03-29 | 2021-08-06 | 江苏省盐业集团有限责任公司 | 添加肽的调味盐及其制备方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
CN101238893B (zh) | 一种高膳食纤维鹰嘴豆营养粉及其制备方法和用途 | |
CN101347253B (zh) | 一种补钙保健悬浮饮料及其制备方法 | |
CN112603971A (zh) | 蛹虫草陈皮中药组合物、制备方法及其用途 | |
CN104543612A (zh) | 一种降压降脂饺子及其制作方法 | |
CN104082672A (zh) | 一种具有降血糖功效的养生粥及其制作方法 | |
CN105061368A (zh) | 一种从玫瑰花中提取维生素c的方法 | |
CN105961685A (zh) | 一种提高免疫女士茶及其制备方法 | |
CN109105861A (zh) | 一种防治四高的海参肽盐及其制备方法 | |
CN106579109A (zh) | 一种解酒护肝柑橘粉的组合物及其制备方法 | |
CN106579108A (zh) | 含柑橘粉的组合物及其制备方法 | |
CN101015591A (zh) | 海参海龙口服液及其制备方法 | |
CN105380041A (zh) | 一种猕猴桃山茱萸枸杞保健饮料的制备工艺 | |
CN101982119B (zh) | 一种蘑菇多元素功能饮料及其制备方法 | |
CN105961710A (zh) | 一种排毒减肥女士茶及其制备方法 | |
CN105961705A (zh) | 一种延缓衰老女士茶及其制备方法 | |
CN1086583C (zh) | 一种壮阳丹 | |
CN108968011A (zh) | 一种三高人群用小分子肽菇盐及其制备方法 | |
CN109717437A (zh) | 一种解酒复合蜂蜜膏及其制备方法 | |
CN109090394A (zh) | 一种预防和治疗四高的低氘水饮料的制备方法 | |
CN109876053A (zh) | 一种祛痘消炎、清肝解毒的组方及其制法 | |
CN105748902B (zh) | 参茸益精片及其制备方法 | |
CN109007120A (zh) | 一种甜菜保健茶的制备方法 | |
CN106333236A (zh) | 一种具有降三高、保护血管、美容强身的野菜杂合面 | |
CN105660878A (zh) | 一种黄瓜木耳魔芋豆腐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190101 |
|
WW01 | Invention patent application withdrawn after publication |